Efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic COVID-19, through evaluation of 130 confirmed cases, with 24 observed in the vaccine group versus 106 in the placebo group....
With the highly transmissible Delta variant accounting for more than a quarter of the new coronavirus cases in the US, the country's health authorities were are reconsidering the mask mandate for the public....
On National Doctor's Day we take a look at the toll the pandemic has put on out healthcare systems and doctors who have to deal with it....
The Delta Covid-19 variant has now been detected in 96 countries, 11 more than last week, the World Health Organization (WHO) said in its latest update. ...
Turkey has ramped up its vaccination efforts against Covid-19 by expanding the mobile healthcare vaccination teams in hopes of realising herd immunity before autumn....
Even as positive cases are declining by the day, deaths due to Covid-19 crossed 35,000 in Karnataka since the pandemic broke out in March 2020, said the state health bulletin on Wednesday....
Britain has reported another 22,868 coronavirus cases in the latest 24-hour period, the highest since January 30 this year, according to official figures released on Monday....
Researchers at Washington University School of Medicine in St. Louis have found evidence that the immune response to Covid-19 vaccines, namely Pfizer and Moderna, is both strong and potentially long-lasting....
The European Center for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) have developed a tool to evaluate the public health effectiveness of contact tracing solutions, according to a statement....
Two doses of CoronaVac, a Covid-19 vaccine manufactured by Chinese firm Sinovac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a results of phase 1/2 clinical trial published in The Lancet Infectious Diseases journal....
